Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Neonode Inc. (NEON)

2.2   0.01 (0.46%) 10-15 09:30
Open: 2.2 Pre. Close: 2.19
High: 2.2 Low: 2.2
Volume: 278 Market Cap: 19M
Neonode Inc develops and licenses user interfaces and optical infrared touch technology. It licenses its multi-touch technology to Original Equipment Manufacturers and Original Design Manufacturers.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.413 - 2.426 2.426 - 2.436
Low: 2.162 - 2.175 2.175 - 2.187
Close: 2.168 - 2.191 2.191 - 2.21

Technical analysis

as of: 2019-10-14 4:47:59 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 2.81     One year: 3.04
Support: Support1: 2.10    Support2: 1.75
Resistance: Resistance1: 2.41    Resistance2: 2.60
Pivot: 2.30
Moving Average: MA(5): 2.29     MA(20): 2.33
MA(100): 2.66     MA(250): 2.62
MACD: MACD(12,26): -0.06     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 60.00     %D(3): 53.83
RSI: RSI(14): 41.79
52-week: High: 3.80  Low: 1.31  Change(%): -15.1
Average Vol(K): 3-Month: 826  10-Days: 655

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
NEON has closed above bottom band by 18.7%. Bollinger Bands are 32.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2019-10-09
13 famous landmarks that no longer look anything like they did when they were built
Aside from the few that have been restored, many monuments that have been standing for hundreds of years don't look anything like they did when they were first built. Landmarks like the Colosseum or the Parthenon have suffered from neglect and natural disasters. From Times Square to the Great Sphinx of Giza, here are the landmarks that no longer look the way they did when they were first built. Visit Insider's homepage for more stories. Many structures around the world have been standing for hundreds of years. Save for a select few that have been meticulously cared for or restored, most look very different now than they did the day they were completed. Here are some landmarks that you might not recognize if you traveled back in time. Before Madison Square Garden, there was Penn Station. Completed in 1910 and once a stunning piece of Roman-inspired architecture , the original Pennsylvania Station in New York City was largely demolished in 1963 to make room for Pennsylvania Plaza and Madison Square Garden.

2019-09-06
The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 5) Bioanalytical Systems, Inc. (NASDAQ: BASI ) NextCure Inc (NASDAQ: NXTC ) Pfenex Inc (NYSE: PFNX ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) ResMed Inc. (NYSE: RMD ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech stocks hitting 52-week lows on Sept. 5) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) BioNano Genomics Inc (NASDAQ: BNGO ) Endologix, Inc. (NASDAQ: ELGX ) Mallinckrodt PLC (NYSE: MNK ) ( retreated amid reports of restructuring ahead of Cleveland opioid litigation) Merit Medical Systems, Inc. (NASDAQ: MMSI ) VBI Vaccines Inc (NASDAQ: VBIV ) Zafgen Inc (NASDAQ: ZFGN ) ( announced decision to explore strategic options) See Also: Biotech Stock On The Radar: Ardelyx Gears Up For FDA Decision Day Stocks In Focus Neon's Process To Predict Neoantigens To Control Tumor Growth Published In Scientific Journal Neon Therapeutics Inc (NASDAQ: NTGN ) announced publication in the scientific journal "Immunity," a breakthrough process for predicting which neoantigens will be presented by MHC Class II molecules in the tumor microenvironment.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Technology
Industry:  Electronic Components
Shares Out. (M) 8.81
Shares Float (M) 4.57
% Held by Insiders 47.92
% Held by Institutions 5.55
Shares Short (K) 303
Shares Short P. Month (K)

Stock Financials

EPS -0.441
Book Value (p.s.) 1.120
PEG Ratio -0.18
Profit Margin -40.45
Operating Margin -47.68
Return on Assets (ttm) -21.2
Return on Equity (ttm) -53.2
Qtrly Rev. Growth -8.8
Gross Profit (p.s.) 0.865
Sales Per Share
EBITDA (p.s.) -0.330
Qtrly Earnings Growth
Operating Cash Flow (M) -2.90
Levered Free Cash Flow (M) -1.14

Stock Valuations

P/E -4.97
P/E Growth Ratio -0.10
P/BV 1.96
P/S 17700826.00
P/CF -6.65

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-10-01
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.